HICHUANG

Huzhou Haichuang Biological Technology Co., Ltd. is a technology-based innovative enterprise specializing in the research and development, production, sales, and related services of biological testing and detection products, rooted in the fields of biotechnology and healthcare. HICHUANG was founded in 2010, with "personalized cancer treatment" as its entry point. It independently developed the ATP-Tumor Drug Sensitivity Test Kit, applied for and obtained relevant domestic invention patents, and received product registration certificates issued by the National Medical Products Administration. Currently, this product has been clinically applied in multiple provinces and cities such as Jiangsu, Guangdong, and Shanghai.